Results for technologies (4)
Advanced filter
Treatment for Inflammatory Diseases and Cancer (No. T4-1733)
The development of kinase inhibitors to treat inflammatory diseases was proved beneficial, however, designing specific inhibitors with minimal side effects and prolonged efficacy is challenging as drug resistance often develops.
Inflammatory diseases include a wide variety of cond...
Read more
5605
Treating Cancer by Inhibiting Nuclear Entry of MAPK Cascade Proteins (No. T4-1446)
Inhibition of Nuclear Entry of MAPK Cascade Proteins as a Novel Mechanism for Treating Cancer
ERK is a major signaling molecule, which plays a driving role in various pathologies, particularly cancer. When not activated ERK is localized to the cytoplasm.
The peptide in...
Read more
5473
Anti-Phospho-ERK (PY193 or PT115) Monoclonal Antibodies (No. M7-176)
176-177 - Monoclonal antibodies to phospho-ERK/Map Kinase Description: Monoclonal antibodies raised against peptides containing the 11 amino acids, HTGFLTEYVAT, corresponding to the ERK activation loop either Tyr -phosphorylated (ERK-PY193), or Thr-phos
...
Read more
5356